MDxHealth SA (MDXH)
1.88
+0.17
(+9.94%)
USD |
NASDAQ |
Nov 22, 16:00
1.84
-0.04
(-2.13%)
After-Hours: 20:00
MDxHealth Enterprise Value: 95.14M for Nov. 22, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 22, 2024 | 95.14M |
| November 21, 2024 | 86.73M |
| November 20, 2024 | 82.27M |
| November 19, 2024 | 79.80M |
| November 18, 2024 | 84.75M |
| November 15, 2024 | 83.26M |
| November 14, 2024 | 88.71M |
| November 13, 2024 | 91.18M |
| November 12, 2024 | 96.63M |
| November 11, 2024 | 100.09M |
| November 08, 2024 | 102.57M |
| November 07, 2024 | 105.54M |
| November 06, 2024 | 105.04M |
| November 05, 2024 | 104.55M |
| November 04, 2024 | 103.06M |
| November 01, 2024 | 105.04M |
| October 31, 2024 | 102.57M |
| October 30, 2024 | 103.06M |
| October 29, 2024 | 102.49M |
| October 28, 2024 | 100.45M |
| October 25, 2024 | 101.39M |
| October 24, 2024 | 97.14M |
| October 23, 2024 | 96.66M |
| October 22, 2024 | 96.66M |
| October 21, 2024 | 96.66M |
| Date | Value |
|---|---|
| October 18, 2024 | 96.66M |
| October 17, 2024 | 96.66M |
| October 16, 2024 | 98.55M |
| October 15, 2024 | 96.66M |
| October 14, 2024 | 97.61M |
| October 11, 2024 | 96.66M |
| October 10, 2024 | 96.66M |
| October 09, 2024 | 97.14M |
| October 08, 2024 | 96.66M |
| October 07, 2024 | 96.66M |
| October 04, 2024 | 96.66M |
| October 03, 2024 | 96.66M |
| October 02, 2024 | 96.90M |
| October 01, 2024 | 98.08M |
| September 30, 2024 | 100.45M |
| September 27, 2024 | 128.50M |
| September 26, 2024 | 85.19M |
| September 25, 2024 | 99.93M |
| September 24, 2024 | 99.38M |
| September 23, 2024 | 102.79M |
| September 20, 2024 | 102.65M |
| September 19, 2024 | 102.38M |
| September 18, 2024 | 100.74M |
| September 17, 2024 | 101.84M |
| September 16, 2024 | 99.93M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-28.97M
Minimum
Aug 17 2022
208.02M
Maximum
May 24 2021
91.66M
Average
90.98M
Median
Jul 14 2023
Enterprise Value Benchmarks
| Galapagos NV | -1.941B |
| UCB SA | 37.88B |
| Mithra Pharmaceuticals SA | -- |
| Nyxoah SA | 241.66M |
| Celyad Oncology SA | -- |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -11.19M |
| Revenue (Quarterly) | 23.32M |
| Total Expenses (Quarterly) | 29.41M |
| EPS Diluted (Quarterly) | -0.40 |
| Gross Profit Margin (Quarterly) | 61.22% |
| Profit Margin (Quarterly) | -47.99% |
| Earnings Yield | -80.85% |
| Normalized Earnings Yield | -80.85 |